PT - JOURNAL ARTICLE AU - Sallam, Malik AU - Al-Salahat, Khaled AU - Eid, Huda AU - Egger, Jan AU - Puladi, Behrus TI - Human versus Artificial Intelligence: ChatGPT-4 Outperforming Bing, Bard, ChatGPT-3.5, and Humans in Clinical Chemistry Multiple-Choice Questions AID - 10.1101/2024.01.08.24300995 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.08.24300995 4099 - http://medrxiv.org/content/early/2024/01/09/2024.01.08.24300995.short 4100 - http://medrxiv.org/content/early/2024/01/09/2024.01.08.24300995.full AB - The advances in large language models (LLMs) are evolving rapidly. Artificial intelligence (AI) chatbots based on LLMs excel in language understanding and generation, with potential utility to transform healthcare education and practice. However, it is important to assess the performance of such AI models in various topics to highlight its strengths and possible limitations. Therefore, this study aimed to evaluate the performance of ChatGPT (GPT-3.5 and GPT-4), Bing, and Bard compared to human students at a postgraduate master’s (MSc) level in Medical Laboratory Sciences. The study design was based on the METRICS checklist for the design and reporting of AI-based studies in healthcare. The study utilized a dataset of 60 Clinical Chemistry multiple-choice questions (MCQs) initially conceived for assessment of 20 MSc students. The revised Bloom’s taxonomy was used as the framework for classifying the MCQs into four cognitive categories: Remember, Understand, Analyze, and Apply. A modified version of the CLEAR tool was used for assessment of the quality of AI-generated content, with Cohen’s κ for inter-rater agreement. Compared to the mean students’ score which was 40/60 (66.8%), GPT-4 scored 54/60 (90.0%), followed by Bing (46/60, 76.7%), GPT-3.5 (44/60, 73.3%), and Bard (40/60, 66.7%). Statistically significant better performance was noted in lower cognitive domains (Remember and Understand) in GPT-3.5, GPT-4, and Bard. The CLEAR scores indicated that ChatGPT-4 performance was “Excellent” compared to “Above average” performance of ChatGPT-3.5, Bing, and Bard. The findings indicated that ChatGPT-4 excelled in the Clinical Chemistry exam, while ChatGPT-3.5, Bing, and Bard were above-average. Given that the MCQs were directed to postgraduate students with a high degree of specialization, the performance of these AI chatbots was remarkable. Due to the risks of academic dishonesty and possible dependence on these AI models, the appropriateness of MCQs as an assessment tool in higher education should be re-evaluated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:In conducting this study, we paid careful attention to ethical implications. Ethical clearance for this research was determined to be non-essential, given the nature of the data involved. The data utilized were entirely anonymized, ensuring no breach of confidentiality or personal privacy. Additionally, the university examination results, which formed part of our dataset, are publicly accessible and open for academic scrutiny. Moreover, the MCQs employed in the study were originally created by the first author. These questions are devoid of any copyright concerns, further reinforcing the ethical integrity of our research approach.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author (M.S.). The data are not publicly available due to the confidentiality of the questions created for an exam purposes.